How the University of California Is Fighting a Proxy Patent Battle for an Expensive Cancer Drug in India

New Delhi: The university appears to be representing pharmaceutical companies Pfizer, Medivation and Astellas in its patent battle. They aren’t telling the Delhi high court this, but they do talk about it in other documents.

https://thewire.in/188045/xtandi-ucla-patent-india-cancer-drug/

 

Advertisements

Panel: Going beyond privacy-The social justice implications of surveillance culture

New Delhi: I was invited to speak on the panel, ‘Going beyond privacy-The social justice implications of surveillance culture,’ at the Digital Citizen Summit in Delhi. For this, I discussed my reporting on the Aadhaar project being rolled out in India and being opposed in various courts.

21 June 2016: And Now, Aadhaar Is Mandatory for TB Patients Seeking Government Cash Benefits
https://thewire.in/149709/aadhaar-manadatory-tb-cash-benefits/

13 September 2016: How Mukul Rohatgi Set the Cat Among Pigeons on Privacy, and Now Says He Didn’t Intend To
https://thewire.in/176316/mukul-rohatgi-aadhaar-privacy-supreme-court/

13 September 2016: Interview: Former AG Mukul Rohatgi Says He Never Intended to Contest India’s Right to Privacy
https://thewire.in/176528/former-ag-mukul-rohatgi-india-right-to-privacy/

How Mukul Rohatgi Set the Cat Among Pigeons on Privacy, and Now Says He Didn’t Intend To

New Delhi: In August, a historic nine-judge bench of the Supreme Court ruled that Indians had a fundamental right to privacy. The matter had been pending in court for two years. The person who told the court that privacy was not a right in India, is former Attorney General of India, Mukul Rohatgi. His statement also stopped 21 other cases which were challenging the Indian government’s implementation of the Aadhaar project.

In a long interview with him soon after he left office he said, “I did not mean that, that privacy is nothing.”

Story: “How Mukul Rohatgi Set the Cat Among Pigeons on Privacy, and Now Says He Didn’t Intend To”
https://thewire.in/176316/mukul-rohatgi-aadhaar-privacy-supreme-court/

Transcript: “Interview: Former AG Mukul Rohatgi Says He Never Intended to Contest India’s Right to Privacy”
https://thewire.in/176528/former-ag-mukul-rohatgi-india-right-to-privacy/

RCEP: New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus

New Delhi: I reported a series of stories on the RCEP trade negotiations, including the round of talks which India hosted in July 2017.

26 July 2017
“Civil Society Group Boycotts RCEP Consultation, Calls for Parliament Debate on Trade Deal”
Worried about the impact of the trade negotiations, a consortium of civil groups called the People’s Resistance Forum has asked for the talks to be called off.
https://thewire.in/161704/rcep-trade-deal-civil-group-boycott/

28 July 2017
“New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus”
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario.
https://thewire.in/162587/new-zealand-rcep-trips-plus-provisions/

24 October 2017
“India Will Not Cross Red Lines on Generic Drugs in RCEP, but Stay Vigilant, Say Officials”
Healthcare watchers are calling on India to resist the free trade agreement’s provisions which could compromise India’s ability to keep supplying cheaper generic drugs to the world.
https://thewire.in/190121/india-red-line-generic-drugs-rcep/

Keep Off Indian Drug Patents Law, US Lawmakers Who Lobbied Modi Are Told

New Delhi: In their letter, many individuals and organisations stated that a country with as much poverty as India should not enforce patents on drugs and vaccines the same way industrialised countries have.
https://thewire.in/153679/us-lawmakers-modi-india-relax-protection-drug-patents